Related Experiment Video

Updated: Nov 10, 2025

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

26.6K

Parkinsonism and Positive Dopamine Transporter Imaging in a Patient with a Novel KMT2B Variant

Jeanne S Feuerstein1,2, Matthew Taylor3, Jennifer J Kwak4

  • 1Department of Neurology University of Colorado School of Medicine Aurora Colorado USA.

Movement Disorders Clinical Practice
|April 5, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
DAT scanDYT‐28KMT2Bdystoniaparkinsonism

More Related Videos

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.5K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.9K

Related Experiment Videos

Last Updated: Nov 10, 2025

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

26.6K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

18.5K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.9K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

702
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
702
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K

Articles linked to this work by shared authors, journal, and citation graph.

Methods in Systematic Reviews of Health Economic Evaluations in Submissions to Health Technology Assessment Agencies: How Systematic Are They, and Does This Matter?

PharmacoEconomics·2026

Lateralized motor control mechanisms underlie lateralized motor deficits in early Parkinson's Disease.

medRxiv : the preprint server for health sciences·2026

Pragmatic Frameworks for Clinical Compensation in Academic Neurology.

Neurology·2026

Carbon Emission Impact of Semaglutide in People with Obesity in the UK Using a Disease Modelling Approach.

PharmacoEconomics·2026

Unveiling the Hidden Rules: Enhancing NMD Prediction for Protein-Truncating Variants.

bioRxiv : the preprint server for biology·2026

Disease-Duration-Specific Percentiles for Prospective Subtyping of Parkinson's Disease: A PPMI-Based Study.

Movement disorders clinical practice·2026

Persistent Therapeutic Burden after Device-Aided Therapy in Parkinson's Disease: Insights from Post-DAT MANAGE-PD Assessment.

Movement disorders clinical practice·2026

Caregiver Burden and Its Determinants After Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease: A Cross-Sectional Long-Term Follow-Up Study.

Movement disorders clinical practice·2026

Disease Duration Differentiates Freezing of Gait Response to Subthalamic and Nigral Stimulation for Parkinson's Disease in an Exploratory Multicenter Controlled Trial.

Movement disorders clinical practice·2026

Genotype-Phenotype Correlations in THAP1-Associated Dystonia: A Multicentric Observational Study.

Movement disorders clinical practice·2026

Cervical Dystonia Treatment with Injections Supplemented by Transcranial Magnetic Stimulation: The D-TWIST Pilot Randomized Controlled Trial.

Movement disorders clinical practice·2026

Longitudinal Cognitive Function in Progressive Supranuclear Palsy-A Review of the Evidence for Progression.

Movement disorders clinical practice·2026

Anterior Corneal Higher-Order Aberrations and Quantitative Macular OCT Angiography Metrics in Healthy Eyes: A Cross-Sectional Study.

Seminars in ophthalmology·2026

Imaging Pars Plana in Acute Anterior Uveitis: Association with Inflammatory Activity.

Ocular immunology and inflammation·2026

Acute Inner Foveal Toxoplasmic Maculopathy: An Atypical Manifestation of Ocular Toxoplasmosis.

Ocular immunology and inflammation·2026

Cardiometabolic Assessment in Patients with Overweight, Obesity, or Type 2 Diabetes Undergoing Artificial Intelligence-Based Retinal Screening: A Real-World Evidence Study.

Metabolic syndrome and related disorders·2026

Effect of Working Distance on Wesson Card Fixation Disparity and Its Clinical Predictors in Symptomatic Patients.

Clinical optometry·2026

The Eye-Brain Axis in High Myopia: From Retinal Deformation to Cortical Network Reorganization.

Eye and brain·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us